Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. (WeightWatchers), trading under the symbol WW, is frequently in the news for developments in science-backed weight management, clinical programs, and digital health innovation. Company announcements emphasize its role as a global leader in weight health, combining behavioral programs, clinical care, GLP‑1 medications when appropriate, and technology-enabled support.
News about WeightWatchers often covers updates to its integrated GLP‑1 platform, including the WeightWatchers Med+ program and the GLP‑1 Success behavioral support experience. Releases have highlighted access to FDA‑approved GLP‑1 treatments, such as an oral formulation of Wegovy, and the company’s positioning as a NovoCare Recognized Care Provider. These stories focus on how WeightWatchers pairs medication access with evidence‑based nutrition, coaching, and community to improve outcomes.
Investors and observers will also find coverage of new product and feature launches within the WeightWatchers app, such as the Weight Health Score, AI Body Scanner, fitness content partnerships, and configurable Modes that adjust support as members move from weight loss to maintenance. Additional news items include the launch of specialized programs like WeightWatchers for Menopause, the publication of WeightWatchers for Business annual results, collaborations with partners like Amazon Pharmacy, and the introduction of the WeightWatchers Awards for health and wellness products.
On this news page, readers can track earnings announcements, conference participation, leadership appointments, and strategic initiatives related to WeightWatchers’ transformation in the GLP‑1 era. For those following WW stock or the broader weight health sector, the news feed provides a centralized view of how the company is evolving its behavioral and clinical businesses, expanding partnerships, and refining its global weight management platform.
WW International (NASDAQ: WW) has successfully acquired Weekend Health, Inc., a telehealth platform focused on chronic weight management. This acquisition aims to enhance WW's capabilities by integrating medication management and clinical care, aligning with the company's strategy to expand its market presence. WW's CEO, Sima Sistani, emphasized the importance of integrating clinical interventions for individuals qualified for medication. This step is expected to provide sustainable, science-backed weight health solutions, acknowledging the advancements in chronic weight management medications.
WW International, Inc. (NASDAQ: WW) announced significant changes to its Board of Directors as part of the preparations for the 2023 Annual Meeting on May 9, 2023. Chairman Raymond Debbane and Director Jonas Fajgenbaum will not seek re-election. Thilo Semmelbauer, who has been a Board member since 2016, has been appointed as the new Chairman effective May 9, 2023. Debbane, in his statement, highlighted WW's evolution over 23 years and expressed confidence in Semmelbauer's leadership. Semmelbauer has extensive experience, including previous roles within WW and as Managing Director at Insight Partners.
WW International, Inc. (NASDAQ: WW) reported its fourth quarter and full year fiscal 2022 results, highlighting an operating loss of $50.8 million and $283.0 million for the quarter and year respectively. Revenues decreased to $223.9 million in Q4 2022, a decline of 18.8% year-over-year, primarily due to a 14.9% drop in subscribers, totaling 3.5 million. The company also announced the acquisition of Sequence, a digital health platform valued at $132 million. Adjusted operating income for Q4 was $24.2 million, down 55.8% year-over-year. The Q1 2023 revenue guidance stands at approximately $235 million, with a projected operating loss of $30 to $35 million.
WW International has announced its acquisition of Weekend Health, operating as Sequence, for $132 million in a cash and equity deal. This strategic move aims to integrate Sequence's telehealth platform, which focuses on chronic weight management, with WeightWatchers’ nutrition and behavior-change programs. Sequence has generated an annual revenue run-rate of approximately $25 million and serves around 24,000 members. The deal is set to close in Q2 2023, contingent on customary conditions. The acquisition is expected to enhance the company’s offerings in the weight management sector, leveraging both technology and clinical support.
WW International, known as WeightWatchers, announces its participation at the Morgan Stanley Technology, Media and Telecom Conference on March 8, 2023, at 11:00 am ET. CEO Sima Sistani will deliver the presentation. Investors can access the live audio webcast on the corporate website under the Investors section, with an archive available for 30 days. WeightWatchers focuses on helping individuals adopt healthy habits through its comprehensive weight management program, leveraging technology, tools, and expert coaching developed over nearly six decades.
WW International, Inc. (NASDAQ: WW) has announced it will release its 2022 fourth quarter and full year results after the market closes on March 6, 2023. A conference call is scheduled for 5:00 p.m. ET that same day, where CEO Sima Sistani and Interim Principal Financial Officer Heather Stark will discuss the results and address questions from investors. A live webcast of the call will be available on the company's corporate website, alongside supplemental investor materials. The webcast replay will remain accessible for approximately 90 days.
WW is recognized for its human-centric technology and leading weight management program, promoting healthy habits for nearly six decades.
WW International announced significant leadership changes, including the departure of Amy O'Keefe as Chief Financial Officer, effective December 2, 2022. Heather Stark will serve as interim Principal Financial Officer. Tiffany Stevenson has been appointed Chief People Officer, effective January 2023, while David Cohen has been named Chief Data Officer. CEO Sima Sistani expressed gratitude for O'Keefe's leadership and emphasized the appointment of Stevenson and Cohen as pivotal for the company's goal of becoming more tech-centric and optimizing for profitable growth.
WW International, Inc. (NASDAQ: WW) reported Q3 2022 results with revenues at $249.7 million, reflecting a 14.9% decline year-over-year. The company recorded an operating loss of $254.5 million, influenced by $312.7 million in non-cash intangible impairment charges. Q3 adjusted operating income was $61.9 million, down 30.0% year-over-year. The end of period subscribers decreased by 15.0% to 3.8 million. For FY 2022, revenue guidance has been revised to approximately $1.04 billion, and GAAP diluted net loss per share is expected between ($3.16) and ($3.21).
WW International, Inc. (NASDAQ: WW) will announce its third-quarter 2022 results on November 3, 2022, after market close. A conference call will follow at 5:00 p.m. ET, featuring CEO Sima Sistani and CFO Amy O’Keefe discussing the results and answering investor questions. The call can be accessed via the company's website, with supplemental materials available beforehand. The company emphasizes its commitment to supporting members in achieving healthy habits through its weight management program, leveraging nearly six decades of experience.
WW International reported Q2 2022 revenues of $269.5 million, down 13.5% year-over-year. The company had 4.3 million end-of-period subscribers, a 12.3% decline compared to the previous year. Operating income fell to $13.4 million, a 77.6% drop from Q2 2021. The company recorded non-cash impairment charges of $26.4 million and revised its full-year guidance to revenues between $1.05 billion and $1.09 billion. Despite these challenges, adjusted operating income was $58.3 million, reflecting cost management efforts.